FDA LAMICTAL NDA 020241 Approval Package — Reviews & Approval Records

This FOIAdocs regulatory document collection brings together FDA approval records for LAMICTAL, NDA 020241. The package contains 58 FDA documents totaling 2,552 pages, organized by original application and supplemental submission.

Research-ready collection with the FDA documents preserved as individual PDFs and organized by regulatory submission.

What's included

• Original FDA approval records
• 32 supplemental submissions represented
• 2 FDA review documents
• 28 approval letters
• 28 labeling documents
• FOIAdocs document index and detailed manifest

Package format: Organized ZIP collection with individual FDA PDFs grouped by regulatory submission, plus a FOIAdocs document index and manifest.

Application: NDA 020241
Product: LAMICTAL
Sponsor: GLAXOSMITHKLINE LLC
Documents: 58
Pages: 2,552
Coverage: Original approval + 32 supplemental submissions represented